TCRX logo

TScan Therapeutics (TCRX) Accounts Receivable

Quarterly Accounts Receivable

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

TCRX Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$31.93 M
TCRX quarterly accounts receivable is currently at an all-time high

3-Year Low

$31.93 M
TCRX quarterly accounts receivable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
TCRX next earnings announcement is scheduled for Mar 6, 2025

OtherTCRXbalance sheetmetrics:

Quarterly Accounts Payable

$3.65 M
TCRX quarterly accounts payable is $3.65 million

Quarterly Total Assets

$348.03 M
TCRX quarterly total assets is $348.03 million

Quarterly Total Liabilities

$118.94 M
TCRX quarterly total liabilities is $118.94 million

Quarterly Cash And Cash Equivalents

$133.12 M
TCRX quarterly cash and cash equivalents is $133.12 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TCRX Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

TCRX Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

TScan Therapeutics Accounts Receivable History

DateAnnualQuarterly
DateAnnualQuarterly
Jun 2023
-
$31.93 M

FAQ

  • What is the all time high quarterly accounts receivable for TScan Therapeutics?

What is the all time high quarterly accounts receivable for TScan Therapeutics?

TScan Therapeutics all-time high quarterly accounts receivable is $31.93 M